# Nuo Therapeutics, Inc.: Form 8-K, filed Oct 6, 2026

- Company: [Nuo Therapeutics, Inc.](/companies/aurx.md) (CIK 1091596)
- Form: 8-K
- Filed: 2026-10-06
- Accepted by EDGAR: Oct 6, 2026, 20:57 ET
- Period: 2026-09-30
- Accession: 0001437749-26-032242
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1091596/000143774926032242/aurx20261006c_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1091596/000143774926032242/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1091596/000143774926032242/aurx20261006c_8k.htm

Filed Oct 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-032242. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.